April 2025 FDA Recall Drug by Nubratori, Inc
D-0392-2025 - Labeling

This Class II drug recall was voluntarily initiated by Nubratori, Inc on April 15, 2025 for the product Drug. The FDA reported the reason for recall as labeling. The product was distributed in PA and CA. and the recall is currently ongoing.

Recall Number: D-0392-2025

Reason for Recall
Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024, however, the outer box on some of the Dexonto 0.4% are labeled incorrectly with a BUD of 12/25/2025.
Initiated
04-15-2025
Reported
05-07-2025
Quantity
20 boxes

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Dexonto 0.4% (dexamethasone sodium phosphate) solution 20 mg/5 mL (4 mg/mL), Rx Only, 12 - 5 mL Single Dose Units per box, Preservative Free, For Iontophoresis Use Only, Non-Sterile Product, Not for Injection, NUBRATORI RX, 381 Van Ness Ave# 1507, CA 90501, NDC 71300-6564-1 (box), 71300-6564-3 (vial).

Batch or Lot Expiration Information

Lot# : C04292401X1, BUD: 12/25/2025 (box).